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httpcense.Abstract Background: Chronic obstructive pulmonary disease (COPD) is a common entity in
clinical practice. Development of right ventricular hypertrophy and eventual right side heart failure
is also common in such patients. However, some disturbance in left ventricular (LV) function has
been observed among such patients.
Objectives: The aim of this study was to evaluate LV function in patients with chronic obstruc-
tive pulmonary disease (COPD) with or without pulmonary hypertension.
Patients and methods: Thirty-six patients with COPD without additional cardiac diseases and 12
age and sex-matched healthy subjects were enrolled into the study. All patients underwent spirom-
etry, standard and tissue Doppler echocardiography.
Results: 20 COPD patients (55.6%) had pulmonary hypertension. Left ventricular systolic func-
tion did not differ between patient and control groups. However the difference between both groups
was signiﬁcant regarding left ventricular diastolic function and left ventricular global function. Left
ventricular diastolic function and global function differed signiﬁcantly between different COPD
grades. Patients with pulmonary hypertension had signiﬁcantly higher heart rate, less E wave peak
velocity (measured by DTI) (P 6 0.05), less E/A ratio (measured by DTI) (P 6 0.01) and E/A ratio
(measured by ﬂow) and higher myocardial performance index (P 6 0.05) than normal pulmonary
pressure patients.
Conclusion: Left ventricular diastolic function and LV global function are affected in COPD
patients especially with progression of the disease. COPD patients with pulmonary hypertensionest Department, Menouﬁya
le: +20 1006896262.
m (R.A. El Wahsh).
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576 R.A. El Wahsh et al.are more liable to LV diastolic and global dysfunction than normal pulmonary pressure COPD
patients. Doppler tissue echocardiography is a better tool in the assessment of left ventricular
function.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. Open access under CC BY-NC-ND license.Introduction
Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality throughout the
world. Many people suffer from this disease for years and
die prematurely from it or its complications. COPD is the
fourth leading cause of death in the world [1], and further in-
creases in its prevalence and mortality can be predicted in the
coming decades [2].
Pulmonary hypertension (PH) is an important complication
in the natural history of chronic obstructive pulmonary disease
(COPD). Its presence is associated with reduced survival and
greater use of healthcare resources [3].
Cor pulmonale, which can occur in very severe COPD, is
characterized by elevated pulmonary vascular resistance and
right heart failure, with associated reductions in left ventricular
ﬁlling, left ventricular stroke volume, and cardiac output,
although left ventricular ejection fraction is generally pre-
served [4]. This disorder may occur as a result of various mech-
anisms, including loss of pulmonary vascular capacity due to
parenchymal destruction, hypoxic pulmonary arterial vaso-
constriction [5] and pulmonary hyperinﬂation with elevated
intrathoracic pressure [6].Aim
The aim of this study was to evaluate LV function in patients
with chronic obstructive pulmonary disease (COPD) with or
without pulmonary hypertension.Patients and methods
This study population included 36 patients with stable COPD
conﬁrmed by medical history and pulmonary function tests
who were admitted to Chest Department, Menouﬁya Univer-
sity Hospitals in the period from May 2010 to August 2011.
Twelve healthy age and sex matched persons with normal spi-
rometry were used as a control group for comparison.Exclusion criteria
Exclusion criteria were as follows: (1) other pulmonary dis-
eases as pulmonary tuberculosis, bronchiectasis, interstitial
pulmonary disease, etc. (2) unstable cardiorespiratory status,
deﬁned as the occurrence of respiratory failure, bronchopul-
monary infection, or congestive heart failure in the previous
2 months; (3) structural diseases of the heart (valvular heart
disease, congenital heart disease, and cardiomyopathy) (3)
ischemic heart disease deﬁned as typical angina pectoris, prior
myocardial infarction, positive exercise test result, positive
myocardial scintigraphy or positive coronary angiography
ﬁndings.Methods
After having an informed consent from all patients, every one
of them underwent the following procedures: resting ECG
tracing, systolic and diastolic blood pressure measurement,
echocardiography and resting spirometry.
Echocardiography was performed in all patients according
to the same protocol with the use of GE Vivid 5 Vingmed;
Horten, Norway machine equipped with 1.5–4 MHz sector
transducer probe and included the following:
(A) Conventional echocardiography
– Measurement of LV EF% by M-mode by measurement of
LV systolic and diastolic dimensions obtained through
long-axis parasternal approach in M-mode projection.
– LV diastolic ﬁlling patterns were determined by the mitral
inﬂow pulsed wave Doppler examination. In the apical 4-
chamber view, the Doppler sample volume was placed in
the middle of LV inﬂow tract 1 cm below the plane of mitral
annulus between the mitral leaﬂet tips, where maximal ﬂow
velocity in early and late diastole was recorded [7].
The diastolic parameters were measured from at least three
beats and were deﬁned as follows: E-wave, early maximal
transmitral ﬂow velocity; A-wave, peak velocity during atrial
contraction in late diastole; and ratio between the early peak
transmitral ﬂow velocity (E) and late peak atrial systolic veloc-
ity (A) [E/A ratio].
– The right ventricular systolic pressure (RVSP) was obtained
from the velocity of tricuspid regurgitation. (Tricuspid
regurgitation velocity P2.9 m/s). The value of 10 mmHg,
obtained from the modiﬁed Bernoullie equation was added
to the pressure gradient between the right ventricle and
right atrium, as the expected right atrium v wave pressure
[8]. As pulmonary stenosis was excluded in all patients, it
was agreed that the RVSP value obtained, relates to the pul-
monary artery pressure.
(B) Pulsed wave DTI
The pulsed wave Doppler tissue imaging (PW. DTI) was
performed using the same machine. From the apical 4 and 2-
chamber views, the Doppler sample volume was placed at four
different sites of the mitral annulus: anterior, lateral, septal
and inferior sites in order to record major velocity time inter-
vals: IVCT (isovolumetric contraction time), IVRT (isovolu-
metric relaxation time) and S wave duration (ejection time).
The regional myocardial velocity waves were systolic veloc-
ity (Swave; cm/s), peak early diastolic ﬁlling velocity (Em; cm/s)
and peak late diastolic ﬁlling velocity (Am; cm/s), also Em/Am
ratio and Eﬂow/Em were calculated [9].
Myocardial performance index (MPI) was calculated by the
sum of isovolumic contraction time and relaxation time
divided by ejection time. Mean MPI value was calculated [10].
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It was done to all patients using Quark PFT spirometry. Pa-
tients were diagnosed to have COPD if they had FEV1/FVC
ratio less than 0.70. Severity of COPD was evaluated accord-
ing to GOLD 2010 [11], and patients were classiﬁed into four
groups as follows:
 Stage I (Mild): post bronchodilator FEV1P 80%
predicted
 Stage II (Moderate): 50%6 post bronchodilator
FEV1 < 80% predicted
 Stage III (Severe): 30%6 post bronchodilator
FEV1 < 50% predicted
 Stage IV (Very severe): post bronchodilator FEV1 < 30%
predicted or <50% predicted plus chronic respiratory
failure.
Statistical analysis
All data were presented as mean ± SD unless otherwise stated.
Comparisons were performed by unpaired t tests for quantita-
tive data. For qualitative data, v2 was used. P value of <0.05
was used to indicate differences between the groups that were
statistically signiﬁcant. Data analysis was performed with a
commercially available statistical analysis software package
(SPSS 16.0 for Windows; SPSS; Chicago, IL, USA).Results
See Figure 1 and Tables 1–6.Discussion
The present work included 30 male (83.3%) and 6 female pa-
tients (16.7%). The mean age of included patients was
55.1 ± 7.3 years. There was a non signiﬁcant difference be-
tween COPD patient and control groups regarding age and
gender.Figure 1 DTI of the septal mitral annulus Lt. picture: IC, isovolumic
A, late diastolic mitral annular wave. RT. picture: Myocardial perf
contraction time (ICT) and relaxation time (IRT) divided by ejectionIn the present study, 20 COPD patients (55.6%) had pul-
monary hypertension with a highly statistically signiﬁcant dif-
ference between patient and control groups.
Pulmonary hypertension is a common complication seen in
patients with advanced chronic obstructive pulmonary disease
(COPD). It has clear effects on both morbidity and mortality
[12].
Although the true prevalence of PH in COPD is unknown,
an elevation of pulmonary arterial pressure is reported to oc-
cur in 20–90% of patients when measured by right heart cath-
eterization with some evidence that pulmonary hemodynamics
worsen with worsening airﬂow obstruction [13–18].
In the present study, there was a highly statistically signiﬁ-
cant difference in heart rate between patient and control
groups, it also increased signiﬁcantly with increasing the sever-
ity of COPD and in COPD patients with pulmonary hyperten-
sion. This could be explained by the effect of hypoxia and
hypercapnea as stimulants to the sympathetic system, by the
frequent association of autonomic neuropathy in COPD as
the para-sympathetic activity was found to be signiﬁcantly re-
duced in COPD, while there was sympatho excitation, and ﬁ-
nally as a side effect to the COPD medications as
bronchodilators [19,20].
Echocardiographic assessment of left ventricular systolic
function (ejection fraction and S wave peak velocity) revealed
a nonsigniﬁcant difference between patient and control groups.
However the difference between both groups was signiﬁcant
regarding left ventricular diastolic function (Ewave peak veloc-
ity by mitral ﬂow, E wave peak velocity by DTI, Eﬂow/Em ratio,
Em/Am ratio by DTI, Eﬂow/Aﬂow ratio by ﬂow, isovolumetric
relaxation time IVRT) and left ventricular global function
(myocardial performance index MPI).
An increase in right ventricular (RV) afterload induces a
left ventricular (LV) diastolic dysfunction because of biventric-
ular interdependence. An increase in RV afterload is common
in COPD patients. Transthoracic echocardiography (TTE) can
estimate LV diastolic function using early (E) and late (A) peak
diastolic velocities measured with Doppler transmitral ﬂow,
and tissue Doppler imaging of mitral annulus velocities includ-
ing early (Ea) peak diastolic velocity [21]. Lamia et al. [21]
studied sixteen COPD patients and 16 control subjects, they
excluded patients with a LV systolic dysfunction or any other
reason of LV diastolic dysfunction. They found that the Econtraction wave; S, S wave; E, early diastolic mitral annular wave;
ormance index (MPI) was calculated by the sum of isovolumic
time (s duration).
Table 1 Statistical comparison between patient and control groups in general characteristics.
Character Patient group, N= 36 Control group, N= 12 P value
Gender n (%)
Male 30 (83.3%) 6 (50%) >0.05
Female 6 (16.7%) 6 (50%)
Age in years (mean ± SD) 55.1 ± 7.3 51.9 ± 9.7 >0.05
Table 3 Statistical comparison between the four grades of COPD patients in general characteristics.
Character Mild COPD N= 8 Mod. COPD N= 10 Severe COPD N= 9 Very severe COPD N= 9 P value
Gender
Male 7 (87.5%) 9 (90%) 8 (88.8%) 6 (66.7%) >0.05
Female 1 (12.5%) 1 (10%) 1 (11.2%) 3 (33.3)
Age (mean ± SD) 53 ± 10.5 58.9 ± 7.4 54.8 ± 9.1 52.8 ± 8.2 >0.05
Table 2 Statistical comparison between patient and control groups in echocardiographic ﬁndings.
Echocardiographic ﬁnding Patient group (N= 36) Control group (N= 12) P-value
Heart rate (mean ± SD) 94.85 ± 8.5 80.93 ± 9.78 60.001
Pulmonary hypertension
Yes n (%) 20 (55.6%) 0 (0%) 60.001
No n (%) 16 (44.4%) 12 (100%)
Left ventricular systolic function
Ejection fraction (mean ± SD) 66.44 ± 5.64 66.33 ± 5.25 >0.05
S wave peak velocity (cm/s) (mean ± SD) 8.01 ± 1.52 9.23 ± 1.28 >0.05
Left ventricular diastolic function
E wave peak velocity by mitral ﬂow (Eﬂow) (m/s) (mean ± SD) 0.54 ± 0.12 0.64 ± 0.22 <0.05
E/A by ﬂow (mean ± SD) 0.92 ± 0.14 1.06 ± 0.12 60.01
E wave peak velocity by DTI (Em) (cm/s) (mean ± SD) 8.53 ± 1.59 12.39 ± 1.88 60.001
Em/Am by DTI (mean ± SD) 0.75 ± 0.1 1.45 ± 0.35 60.001
Eﬂow/Em (mean ± SD) 6.52 ± 1.79 5.12 ± 1.67 60.05
IVRT (msec.) (mean ± SD) 74.55 ± 8.15 67.92 ± 3.13 60.001
Left ventricular global function
MPI (mean ± SD) 0.65 ± 0.11 0.46 ± 0.02 <0.001
578 R.A. El Wahsh et al.wave was signiﬁcantly lower and the A wave was signiﬁcantly
higher in COPD patients compared to control subjects. The E/
A ratio was signiﬁcantly lower in COPD patients as well as the
Ea velocity and the E/Ea ratio which were signiﬁcantly higher
in COPD patients, indicating a LV diastolic dysfunction. They
concluded that LV diastolic dysfunction does exist in COPD
patients with increased RV afterload and no pre-existing LV
dysfunction.
In the present study, the difference between the four grades
of COPD as regarding age and gender was statistically non
signiﬁcant.
In the studied COPD patients, one mild (12.5%), 5 moder-
ate (50%), 5 severe (55.6%), and 9 very severe (100%) COPD
patients had pulmonary hypertension. The difference between
mild and very severe COPD was highly signiﬁcant (P 6 0.01),
and between mild versus severe and moderate versus very se-
vere COPD patients was signiﬁcant (P 6 0.05).
In a study on 40 COPD patients by Jupta et al. [22], the fre-
quencies of PH in mild, moderate, severe, and very severeCOPD were 16.67%, 54.55%, 60.00%, and 83.33%,
respectively.
The effects of COPD and emphysema on the heart have
long been recognized but have been studied principally in very
severe COPD [23]. Clinical data on pulmonary hypertension in
milder lung disease are limited owing to the invasiveness of the
usual reference measure, that is, right heart catheterization. A
study involving patients with mild-to-moderate COPD that
used right heart catheterization showed increases in pulmonary
artery pressure with exercise [24]. Anatomical studies showed
proliferation of smooth-muscle cells in pulmonary arteries
from patients with mild-to moderate COPD [25,26] and from
smokers without COPD [27], which suggests subclinical in-
creases in pulmonary vascular resistance in patients with
mild-to-moderate COPD and in smokers without spirometri-
cally deﬁned COPD.
Barbera` and Blanco [3] found that the prevalence of PH is
high in patients with advanced COPD, whereas in milder forms
it might not be present at rest but may develop during exercise.
Table 4 Incidence of pulmonary hypertension in the four grades of COPD patients.
Mild COPD N= 8 Mod. COPD N= 10 Severe COPD N= 9 Very severe COPD N= 9
PHTN n (%) 1 (12.5%) 5 (50%) 5 (55.6%) 9 (100%)
Table 6 Statistical comparison between COPD patients with and without pulmonary hypertension regarding echocardiographic
ﬁndings.
Echocardiographic ﬁnding COPD patients with pulmonary
hypertension (n= 20)
COPD patients without pulmonary
hypertension (n= 16)
P-value
Heart rate (mean ± SD) 98.71 ± 11.32 90.88 ± 7.61 60.05
Left ventricular systolic function
Ejection fraction (mean ± SD) 68.59 ± 5.92 66.42 ± 5.35 >0.05
S wave peak velocity (cm/s) (mean ± SD) 9.34 ± 1.7 8.59 ± 1.2 >0.05
Left ventricular diastolic function
E wave peak velocity by mitral ﬂow (Eﬂow) (m/s) (mean ± SD) 0.55 ± 0.12 0.54 ± 0.12 >0.05
E/A by ﬂow (mean ± SD) 0.67 ± 0.08 0.77 ± 0.18 60.05
E wave peak velocity by DTI (Em) (cm/s) (mean ± SD) 7.11 ± 1.38 8.28 ± 1.69 60.05
Eﬂow/Em (mean ± SD) 6.22 ± 1.48 6.88 ± 2.12 >0.05
Em/Am by DTI (mean ± SD) 0.65 ± 0.08 0.76 ± 0.12 60.01
IVRT(msec.) (mean ± SD) 74.46 ± 8.39 74.66 ± 8.12 >0.05
Left ventricular global function
MPI (mean ± SD) 0.69 ± 0.11 0.61 ± 0.07 60.05
Table 5 Statistical comparison between the four grades of COPD patients in echocardiographic ﬁndings.












Pulmonary hypertension >0.05 60.05 60.01 >0.05 60.05 >0.05
Left ventricular systolic function
Ejection fraction >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
S wave peak velocity (cm/s) >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
Left ventricular diastolic function
E wave peak velocity by mitral ﬂow (Eﬂow) (cm/s) >0.05 >0.05 60.05 >0.05 >0.05 >0.05
E/A by ﬂow >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
E wave peak velocity by DTI (Em) (cm/s) >0.05 <0.05 <0.05 >0.05 <0.05 >0.05
Eﬂow/Em >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
Em/Am by DTI >0.05 <0.05 <0.05 >0.05 <0.05 >0.05
IVRT (ms.) >0.05 <0.05 <0.05 >0.05 >0.05 >0.05
Left ventricular global function
MPI >0.05 <0.001 <0.001 <0.001 <0.001 <0.05
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monary blood pressure are well known to complicate the clin-
ical course of COPD and co-relate inversely with survival.
Signiﬁcant structural changes occur in the pulmonary circula-
tion in patients with COPD. The presence of hypoxemia and
chronic ventilator insufﬁciency is associated with early evidence
of intimal thickening and medial hypertrophy in the smaller
branches of the pulmonary arteries. Coupled with these patho-
logical changes are pulmonary vasoconstriction arising from
the presence of alveolar hypoxemia, destruction of pulmonary
vascular bed, changes in intrinsic pulmonary vasodilator sub-
stances (such as decrease in PGI2S (prostacyclin synthase), de-
crease in eNOS (endothelial nitric oxide synthase), and increasein ET1 (endothelin1) leads to remodeling, increase in blood vis-
cosity, and alteration in respiratory mechanics. All these lead to
a signiﬁcant increase in pulmonary vascular resistance, the con-
sequence of which is pulmonary hypertension [22].
In the present work, left ventricular systolic function did
not signiﬁcantly differ between different COPD grades, while
left ventricular diastolic function assessment revealed a statis-
tically signiﬁcant difference in E wave peak velocity and E/A
ratio (both measured by DTI echocardiography) between mild
vs. severe, mild vs. very severe and moderate vs. very severe
COPD grades. Also, isovolumetric relaxation time (IVRT)
was signiﬁcantly shorter in mild vs. severe and in mild vs. very
severe COPD patients. Left ventricular global function mea-
580 R.A. El Wahsh et al.sured by myocardial performance index (MPI) was signiﬁ-
cantly different between mild vs. severe, mild vs. very severe,
moderate vs. severe, moderate vs. very severe, and severe vs.
very severe COPD grades.
Funk et al. [28] found LV diastolic dysfunction (LVDD) in
COPD patients with normal pulmonary arterial pressure and it
increased with right ventricular afterload. Moreover, Gupta
et al. [22], found LVDD in 47.5% of patients, out of which
16 patients had PH and 3 did not have PH, various mecha-
nisms might explain the presence of left ventricular diastolic
dysfunction in COPD patients. This may be due to chronic
hypoxemia leading to abnormalities of myocardial relaxation,
lung hyperinﬂation and distension leading to increased stiff-
ness of the parietal pleura and thus of the wall of cardiac fossa
leading to added load on ventricle, and also due to ventricular
interdependence.
In the present study, by comparing echocardiographic ﬁnd-
ings in COPD patients with and without pulmonary hyperten-
sion, we found that patients with pulmonary hypertension had
signiﬁcantly higher heart rate, less E wave peak velocity (mea-
sured by DTI) than normal pulmonary pressure patients
(P 6 0.05). There was a highly statistically signiﬁcant differ-
ence between both groups in E/A ratio (measured by DTI)
(P 6 0.01) and a statistically signiﬁcant difference in E/A ratio
(measured by ﬂow) and myocardial performance index.
(P 6 0.05).
Kasner et al. [29] studied LV function in patients with non-
severe idiopathic pulmonary arterial hypertension (IPAH).
They used invasive pressure–volume (PV) loop analysis ob-
tained by conductance catheterization performed at rest and
during atrial pacing in patients with mild IPAH in comparison
to the patients with isolated LV diastolic dysfunction and con-
trols without heart failure symptoms. They found that idio-
pathic pulmonary arterial hypertension impairs LV diastolic
function even in the absence of intrinsic LV disease.
Bhargava and Sunnerhagen [30] found left ventricular re-
gional wall motion early diastolic asynchrony in 11 patients
with pulmonary hypertension. They explained that by the
interventricular interaction caused by pressure gradients across
the septum.
Gan et al. [31] found that stroke volume, left ventricular
end-diastolic volume and left ventricular peak ﬁlling rate were
decreased in PAH patients compared with control subjects.
They concluded that there is an impaired left ventricular ﬁlling
due to right-to-left ventricular interaction in patients with pul-
monary arterial hypertension.
In their study on COPD patients, Suchon´ et al. [32] found
impaired diastolic function in the studied patient group. More-
over, there was a strong correlation between the level of
impairment of diastolic function and the level of pressure in
the pulmonary artery which correlates with other investigators’
ﬁndings [33–36]. The relation between right ventricular pres-
sure and left ventricular diastolic dysfunction in a large group
of cor pulmonale patients of different etiology (including
COPD patients), was conﬁrmed by Mustapha et al. [37]. The
development of relaxation diastolic dysfunction is most prob-
able in patients with severe pulmonary hypertension as sug-
gested by the authors.
Moreover, Barasch et al. [38] found a quantitative relation-
ship between the severity of pulmonary hypertension and LV
diastolic function. They examined by Doppler-echocardiography120 patients with chronic pulmonary hypertension, and found
that only in patients with a systolic pulmonary artery pressure
(SPAP) P60 mmHg is LV diastolic ﬁlling altered in the form
of impaired relaxation pattern. In addition, they also found
that the late systolic and early diastolic interventricular septum
ﬂatting occurs in 70% of patients with SPAPP60 mmHg and
only in 6% of those with SPAP <60 mmHg. They explained
LV diastolic dysfunction in the presence of pulmonary hyper-
tension by abnormal geometrical conﬁguration and motion of
interventricular septum, presence of some degree of LV inter-
stitial edema, which increases the LV wall stiffness and alters
its normal diastolic ﬁlling [39] and the diastolic asynchrony
found in the apical and lateral walls [30]. Also, Moustapha
et al. [37] found that LV diastolic dysfunction of impaired
relaxation type is most commonly seen in patients with severe
PHT but not in mild and moderate PHT and mentioned that
SPAP P60 mmHg is needed to induce changes in the LV dia-
stolic ﬁlling pattern.
In addition, the hypothesis that an abrupt reduction in pul-
monary artery pressure in patients with chronic pulmonary
hypertension results in an early improvement of left ventricular
diastolic function was studied by Dittrich et al. [40] who ana-
lyzed the Doppler indexes of left ventricular diastolic function
and echocardiographic measures of left ventricular volume in
22 patients before and within 1 week after pulmonary throm-
boendarterectomy for chronic thromboembolic pulmonary
hypertension. They found that cardiac index, left ventricular
end-diastolic volume and stroke volume increased signiﬁcantly
after surgery.
In the present study, the left ventricular systolic function
impairment in the course of COPD, was not found (EF and
S wave peak velocity). Suchon´ et al. [32], found that ejection
fraction, shortening fraction and lateral mitral annular peak
systolic velocity (S wave) in COPD patients, were in the nor-
mal value range and did not differ signiﬁcantly from control
group. Similar results were obtained by other investigators
[36,41].
On the other hand, Gupta et al. [22], in their study, found
that left ventricular systolic dysfunction (LVSD) was present
in 7.5% of COPD patients.
In the present work, LV global function measured by myo-
cardial performance index (MPI) (also called TEI index) dif-
fered signiﬁcantly between COPD patients with and without
pulmonary hypertension.
Similar results were obtained by other investigators [41]. As
suggested in the bibliography, in the absence of conditions pri-
marily leading to left ventricular systolic function impairment
(ischemic heart disease, systemic arterial hypertension, etc.),
the derangement of systolic function in the course of COPD
is rarely found, usually in severe pulmonary hypertension
and in patients with right ventricular dysfunction [42].
Conclusion
Left ventricular diastolic function and LV global function are
affected in COPD patients especially with progression of the
disease. COPD patients with pulmonary hypertension are
more liable to LV diastolic and global dysfunction than nor-
mal pulmonary pressure COPD patients. Doppler tissue echo-
cardiography is a better tool in the assessment of left
ventricular function.
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